Compare TLS & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TLS | NAUT |
|---|---|---|
| Founded | 1969 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 358.0M | 125.4M |
| IPO Year | 2020 | 2020 |
| Metric | TLS | NAUT |
|---|---|---|
| Price | $3.99 | $1.03 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $7.90 | $4.00 |
| AVG Volume (30 Days) | 574.7K | ★ 844.7K |
| Earning Date | 05-11-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 31.51 | 16.07 |
| EPS | ★ 0.03 | N/A |
| Revenue | ★ $164,805,000.00 | N/A |
| Revenue This Year | $18.72 | N/A |
| Revenue Next Year | $14.62 | $992.86 |
| P/E Ratio | $131.67 | ★ N/A |
| Revenue Growth | ★ 52.21 | N/A |
| 52 Week Low | $3.79 | $0.68 |
| 52 Week High | $8.36 | $4.31 |
| Indicator | TLS | NAUT |
|---|---|---|
| Relative Strength Index (RSI) | 51.74 | 47.48 |
| Support Level | $3.93 | $0.84 |
| Resistance Level | $5.05 | $2.30 |
| Average True Range (ATR) | 0.21 | 0.09 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 47.13 | 46.35 |
Telos Corp offers technology solutions and services that empower and protect the world's security-conscious organizations. The company delivers efficient, adaptable, and secure solutions that protect people, organizations, and information across government and industry. The company conducts its business through two reportable and operating segments: Security Solutions and Secure Networks. The Security Solutions segment is focused on cybersecurity, cloud, and identity solutions, and secure messaging through Xacta, Telos AMHS, and Telos ID offerings. The Secure Networks segment provides secure networking architectures and solutions to customers through secure mobility solutions, network management, and defense services. The majority of revenue is from Secure Networks.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.